Amylyx Pharmaceuticals (AMLX) Financials: Revenue & Earnings

AMLX price $27.88 -0.42 -1.48%

Ticker
AMLX
Price
$27.88
Change
-0.42 -1.48%
Market cap ?
$3.50B
P/E ?
-18.84
Forward P/E ?
12.63
Dividend yield ?
0.00%
Beta ?
-0.20
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
66
Value
49
Quality
48
Growth
100

Stocklytics score rationale: value 49, quality 48, growth 100.

Financials

2019202020212022202320242025
1426000650000022230000380786000873710000

Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating…

Fair value

AMLX fair value $86.34. Price $27.88. Price is 68% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare AMLX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.38—59.43K
2026-08-06-0.39-0.36——
2026-05-07-0.37-0.34——
2026-03-03-0.30-0.31—-52.00K
2025-11-06-0.37-0.43—52.00K
2025-08-07-0.46-0.44——
2025-05-08-0.42-0.45——
2025-03-04-0.55-0.49665.00K—
2024-11-07-1.07-0.60416.00K31.57M
2024-08-08-0.73-0.381.02M10.66M
2024-05-10-0.46-0.0088.60M98.35M
2024-02-220.070.23108.45M106.96M
2023-11-090.300.44102.69M107.85M
2023-08-100.310.1098.22M92.11M
2023-05-110.02-0.2471.43M87.61M
2023-03-13-0.65-0.7721.89M58.99M
2022-11-10-0.92-0.97345.00K83.33K
2022-08-11-0.93-0.92—125.00K
2022-05-12-0.93-0.75—83.33K
2022-03-30-4.15-0.64——
2022-01-10-0.42—285.00K—
2021-06-30-0.48———
2021-03-31-0.32———
2020-12-31-0.19—350.00K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Quarterly.

Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2018-03-28$0.42—2018-04-02Quarterly
2017-12-28$0.36—2018-01-02Quarterly
2017-09-28$0.24—2017-10-02Quarterly

Insider trades

DateInsiderActionSharesPriceValue
2026-10-05MILNE GEORGE M JRSell30.00K$27.70830.90K
2026-09-10Bedrosian Camille LSell7.95K$32.21256.00K
2026-09-10Bedrosian Camille LSell2.08K$33.0968.86K
2026-09-10FRATES JAMES MSell9.77K$32.27315.19K
2026-09-10FRATES JAMES MSell1.04K$33.2334.63K
2026-09-10Mazzariello GinaSell9.53K$32.46309.14K
2026-09-10Mazzariello GinaSell11$33.34367
2026-09-10Klee Justin B.Sell29.02K$32.13932.55K
2026-09-10Klee Justin B.Sell1.44K$33.1647.71K
2026-09-10Cohen Joshua BSell29.55K$32.16950.04K
2026-09-10Cohen Joshua BSell919$33.1530.46K
2026-08-31Firestone KarenBuy25.00K$5.05126.25K
2026-08-31Firestone KarenBuy25.00K$1.7644.00K
2026-08-31Firestone KarenSell25.00K$1.7644.00K
2026-08-31Firestone KarenSell25.00K$5.05126.25K
2026-08-18FRATES JAMES MBuy22.81K——
2026-08-18Klee Justin B.Buy60.04K——
2026-08-18Mazzariello GinaBuy21.28K——
2026-08-18Bedrosian Camille LBuy22.81K——
2026-08-18Cohen Joshua BBuy60.04K——
2026-07-10Mazzariello GinaSell15.00K$17.61264.12K
2026-07-09Mazzariello GinaSell15.00K$18.32274.75K
2026-06-04Zeiher Bernhardt GBuy24.37K$14.31348.76K
2026-06-04Firestone KarenBuy24.37K$14.31348.76K
2026-06-04Quimi DaphneBuy24.37K$14.31348.76K
2026-06-04MILNE GEORGE M JRBuy24.37K$14.31348.76K
2026-06-04FONTEYNE PAUL R.Buy24.37K$14.31348.76K
2026-05-21Firestone KarenBuy3.80K$13.5151.34K
2026-03-05Cohen Joshua BBuy248.87K——
2026-03-05Cohen Joshua BBuy373.30K$14.105.26M
2026-03-05Mazzariello GinaBuy74.66K——
2026-03-05Mazzariello GinaBuy111.99K$14.101.58M
2026-03-05FRATES JAMES MBuy95.99K——
2026-03-05FRATES JAMES MBuy143.99K$14.102.03M
2026-03-05Klee Justin B.Buy248.87K——
2026-03-05Klee Justin B.Buy373.30K$14.105.26M
2026-03-05Bedrosian Camille LBuy95.99K——
2026-03-05Bedrosian Camille LBuy143.99K$14.102.03M
2026-03-02Klee Justin B.Sell29.28K$14.47423.76K
2026-03-02Cohen Joshua BSell29.28K$14.48424.12K
2026-03-02Bedrosian Camille LSell6.46K$14.5894.21K
2026-03-02FRATES JAMES MSell7.91K$14.52114.85K
2026-03-02Mazzariello GinaSell6.84K$14.5299.38K
2026-02-23Mazzariello GinaSell3.42K$14.1448.35K
2026-02-02FRATES JAMES MSell3.56K$14.6552.10K
2026-02-02Cohen Joshua BSell15.50K$14.68227.59K
2026-02-02Mazzariello GinaSell3.45K$14.6550.52K
2026-02-02Klee Justin B.Sell15.50K$14.69227.62K
2026-01-16Cohen Joshua BBuy2.82K$7.5721.33K
2026-01-16Cohen Joshua BSell1.97K$13.8327.30K
2026-01-16Cohen Joshua BSell2.82K$7.5721.33K
2026-01-16Klee Justin B.Buy2.85K$7.5721.55K
2026-01-16Klee Justin B.Sell2.00K$13.8927.70K
2026-01-16Klee Justin B.Sell2.85K$7.5721.55K
2026-01-15Cohen Joshua BBuy197.18K$7.571.49M
2026-01-15Cohen Joshua BSell136.19K$13.591.85M
2026-01-15Cohen Joshua BSell197.18K$7.571.49M
2026-01-15Klee Justin B.Buy197.15K$7.571.49M
2026-01-15Klee Justin B.Sell136.19K$13.581.85M
2026-01-15Klee Justin B.Sell197.15K$7.571.49M
2026-01-12MILNE GEORGE M JRSell17.78K——
2026-01-06FRATES JAMES MSell3.33K$11.1136.95K
2026-01-06Cohen Joshua BSell7.71K$11.0985.60K
2026-01-06Klee Justin B.Sell7.71K$11.0985.59K
2025-12-23Firestone KarenBuy8.10K$12.45100.84K
2025-12-01Bedrosian Camille LSell6.58K$14.3594.42K
2025-09-30Klee Justin B.Sell29.77K$14.37427.95K
2025-09-30Klee Justin B.Sell200$15.013.00K
2025-09-30Mazzariello GinaSell8.83K$14.58128.67K
2025-09-30FRATES JAMES MSell10.56K$14.65154.65K
2025-09-30Cohen Joshua BSell29.73K$14.34426.47K
2025-09-30Cohen Joshua BSell200$15.003.00K
2025-09-30Bedrosian Camille LSell12.04K$14.58175.52K
2025-08-13Mazzariello GinaSell15.00K$8.34125.05K
2025-08-12Mazzariello GinaSell15.00K$8.07121.10K
2025-06-05FONTEYNE PAUL R.Buy25.00K$5.05126.25K
2025-06-05Firestone KarenBuy25.00K$5.05126.25K
2025-06-05Quimi DaphneBuy25.00K$5.05126.25K
2025-06-05MILNE GEORGE M JRBuy25.00K$5.05126.25K
2025-06-05Zeiher Bernhardt GBuy25.00K$5.05126.25K
2025-05-22Mazzariello GinaSell1.00K——
2025-03-31FRATES JAMES MSell10.90K$3.4737.81K
2025-03-31Bedrosian Camille LSell12.43K$3.4743.08K
2025-03-31Mazzariello GinaSell9.19K$3.4831.95K
2025-03-31Cohen Joshua BSell21.49K$3.4774.48K
2025-03-31Klee Justin B.Sell21.49K$3.4674.45K
2025-03-20Zeiher Bernhardt GBuy10.00K$3.7037.01K
2025-03-06Mazzariello GinaBuy63.85K——
2025-03-06Mazzariello GinaBuy95.78K$3.61345.75K
2025-03-06Bedrosian Camille LBuy68.42K——
2025-03-06Bedrosian Camille LBuy102.63K$3.61370.49K
2025-03-06Klee Justin B.Buy180.12K——
2025-03-06Klee Justin B.Buy270.18K$3.61975.34K
2025-03-06Cohen Joshua BBuy180.12K——
2025-03-06Cohen Joshua BBuy270.18K$3.61975.34K
2025-03-06FRATES JAMES MBuy68.42K——
2025-03-06FRATES JAMES MBuy102.63K$3.61370.49K
2025-03-03Klee Justin B.Sell4.59K$3.1514.48K
2025-03-03Cohen Joshua BSell4.59K$3.1714.55K
2025-03-03Mazzariello GinaSell1.61K$3.125.02K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 223, holders +42 vs prior quarter. Ownership 104.66%.

HolderSharesChangeChange %Value
FMR LLC16.73M97.37K+0.59%300.43M
BLACKROCK, INC.8.83M-1.75K-0.02%158.53M
PERCEPTIVE ADVISORS LLC8.33M50.00K+0.60%149.69M
TCG CROSSOVER MANAGEMENT, LLC6.24M00.00%112.14M
COMMODORE CAPITAL LP5.65M00.00%101.47M
JUPITER TOPCO LLC5.24M5.24MNew94.01M
SATURN V CAPITAL MANAGEMENT LP4.62M274.22K+6.30%83.05M
VANGUARD CAPITAL MANAGEMENT LLC4.22M82.65K+2.00%75.87M
MORGAN STANLEY3.13M955.26K+43.91%56.23M
DRIEHAUS CAPITAL MANAGEMENT LLC3.04M49.82K+1.67%54.54M
FIRST LIGHT ASSET MANAGEMENT, LLC3.02M-167.39K-5.25%54.30M
FRANKLIN TEMPLETON INC2.95M688.66K+30.45%52.99M
GOLDMAN SACHS GROUP INC2.86M232.25K+8.84%51.33M
STATE STREET CORP2.60M240.18K+10.16%46.76M
GEODE CAPITAL MANAGEMENT, LLC2.34M124.38K+5.63%41.95M
JPMORGAN CHASE & CO1.86M1.70M+1067.24%34.92M
ADAGE CAPITAL PARTNERS GP, L.L.C.1.90M-1.66M-46.64%34.12M
SIREN, L.L.C.1.48M250.59K+20.37%26.59M
EVENTIDE ASSET MANAGEMENT, LLC1.33M-186.42K-12.31%23.84M
683 CAPITAL MANAGEMENT, LLC1.28M1.18M+1224.55%22.98M
VANGUARD PORTFOLIO MANAGEMENT LLC1.06M116.75K+12.36%19.07M
ALYESKA INVESTMENT GROUP, L.P.1.05M1.05MNew18.91M
ALMITAS CAPITAL LLC974.88K-1.15M-54.07%17.51M
DIMENSIONAL FUND ADVISORS LP902.46K-729-0.08%16.22M
JONES HILL CAPITAL LP894.06K-704.74K-44.08%16.06M

Earnings and financials

Amylyx Pharmaceuticals, Inc. (AMLX) trades at $27.88, with a market cap of $3.50B and a trailing P/E of -18.84. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2019202020212022202320242025
1426000650000022230000380786000873710000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Amylyx Pharmaceuticals (AMLX) Financials: Revenue & Earnings

AMLX$27.88-0.42 -1.48%

$3.50B

Market Cap

-18.84

P/E

12.63

Forward P/E

66

Score

Price History